Patents Assigned to OptiScan Biomedical Corporation
-
Patent number: 7860543Abstract: In certain embodiments, a method samples a body fluid of a patient. The method includes providing a fluid handling system having one or more fluid passageways. The method further includes infusing an infusion fluid by way of a fluid handling system into a patient through one or more fluid passageways. The method further includes obtaining a sample of body fluid by way of a fluid handling system from a patient through one or more fluid passageways. The obtained sample is no more than 5 milliliters in volume. The method further includes analyzing at least an analyzed portion of the obtained sample by way of an analyte detection system operatively associated with the fluid handling system to determine a concentration of at least one analyte.Type: GrantFiled: August 15, 2006Date of Patent: December 28, 2010Assignee: OptiScan Biomedical CorporationInventors: Bernhard B. Sterling, Jennifer H. Gable, James R. Braig, Mark Wechsler, Peng Zheng, Peter Rule, Richard Keenan
-
Patent number: 7860542Abstract: In certain embodiments, a method samples a body fluid of a patient. The method includes providing a fluid handling system having one or more fluid passageways. The method further includes infusing an infusion fluid by way of a fluid handling system into a patient through one or more fluid passageways. The method further includes obtaining a sample of body fluid by way of a fluid handling system from a patient through one or more fluid passageways. The obtained sample is no more than 400 microliters in volume. The method further includes analyzing at least an analyzed portion of the obtained sample by way of an analyte detection system operatively associated with the fluid handling system to determine a concentration of at least one analyte.Type: GrantFiled: December 21, 2005Date of Patent: December 28, 2010Assignee: OptiScan Biomedical CorporationInventors: Bernhard B. Sterling, Jennifer H. Gable, James R. Braig, Mark Wechsler, Peng Zheng, Peter Rule, Richard Keenan
-
Publication number: 20100221762Abstract: A method and apparatus are described that permit an analyte concentration to be estimated from a measurement in the presence of compounds that interfere with the measurement. The method reduces the error in the analyte concentration in the presence of interferents. The method includes the use of a set of measurements obtained for a large population having a range of known analyte and interfering compound concentrations. From a sample measurement, which may or may not be one of the population, likely present interferents are identified, and a calibration vector is calculated.Type: ApplicationFiled: October 5, 2009Publication date: September 2, 2010Applicant: OPTISCAN BIOMEDICAL CORPORATIONInventors: Bernhard B. Sterling, W. Dale Hall, Kenneth G. Witte, Mark Wechsler, Peng Zheng, Richard Keenan
-
Patent number: 7785258Abstract: In certain embodiments, a method of maintaining health of a patient uses an analyte detection system. The analyte detection system is coupled to the patient such that a bodily fluid of the patient is accessible to the analyte detection system. The method includes automatically initiating and conducting a measurement of an analyte in the bodily fluid using the analyte detection system. The method further includes determining a treatment dose for the patient based on the measurement using the analyte detection system.Type: GrantFiled: December 21, 2005Date of Patent: August 31, 2010Assignee: OptiScan Biomedical CorporationInventors: James R. Braig, Peter Rule
-
Patent number: 7738085Abstract: A reagentless whole-blood analyte detection system that is capable of being deployed near a patient has a source capable of emitting a beam of radiation that includes a spectral band. The whole-blood system also has a detector in an optical path of the beam. The whole-blood system also has a housing that is configured to house the source and the detector. The whole-blood system also has a sample element that is situated in the optical path of the beam. The sample element has a sample cell and a sample cell wall that does not eliminate transmittance of the beam of radiation in the spectral band.Type: GrantFiled: December 23, 2008Date of Patent: June 15, 2010Assignee: OptiScan Biomedical CorporationInventors: James R. Braig, Peter Rule, Philip C. Hartstein, Bernhard B. Sterling, Jennifer H. Gable, Kenneth I. Li
-
Publication number: 20100121170Abstract: Disclosed are methods and apparatuses for determining analyte concentration in a sample such as bodily fluid. Systems and methods disclosed herein can also include a treatment dosing system to infuse or inject a treatment dose (e.g. insulin, dextrose, etc.) and provide glycemic control. The dose of the treatment drug may be based on the patient's calculated sensitivity to treatment dosing, for example. The dose of the treatment drug may be based on the concentration of the analyte or the average value for the concentration of the analyte and/or the rate of change of the value of the concentration of the analyte. Delivery of the treatment drug can be cut off if the determined analyte concentration indicates that continued delivery would be harmful to the patient.Type: ApplicationFiled: September 14, 2009Publication date: May 13, 2010Applicant: OptiScan Biomedical CorporationInventor: Peter Rule
-
Publication number: 20100030137Abstract: An apparatus is provided for monitoring a predetermined parameter of a patient's body fluid while infusing an infusion fluid into the patient. The apparatus comprises an infusion line and a catheter configured for insertion into a blood vessel of the patient, and a reversible infusion pump connected between a source of an infusion fluid and the infusion line and catheter. The apparatus further comprises a body fluid sensor assembly mounted in fluid communication with the infusion line and which includes a first sensor and a sample cell. The first sensor provides a signal indicative of a predetermined parameter of any fluid present in the infusion line. The sample cell is substantially transmissive to light comprising a wavelength ?. The apparatus further comprises a controller that is configured to operate the infusion pump in a forward direction so as to pump the infusion fluid through the infusion line and catheter for infusion into the patient.Type: ApplicationFiled: July 28, 2009Publication date: February 4, 2010Applicant: OPTISCAN BIOMEDICAL CORPORATIONInventors: W. Dale Hall, David N. Callicoat, Jennifer H. Gable, James R. Braig, Kenneth G. Witte, Mark Wechsler, Peter Rule, Richard Keenan
-
Publication number: 20090326343Abstract: A fluid handling module is configured for removable engagement with a reusable main fluid handling instrument. The module includes a module housing and a first fluid passageway extending from the module housing. The first fluid passageway has a patient end remote from the housing. The first fluid passageway is configured to provide fluid communication with a bodily fluid in a patient. A fluid component separator is in fluid communication with the first fluid passageway. The fluid component separator is configured to separate at least one component from a portion of the bodily fluid drawn from the patient. A spectroscopic sample cell is configured to hold at least a portion of the first component.Type: ApplicationFiled: January 26, 2009Publication date: December 31, 2009Applicant: OptiScan Biomedical CorporationInventors: Jennifer H. Gable, James R. Braig, Kenneth I. Li, Mark Wechsler, Peng Zheng, Richard Keenan
-
Patent number: 7593108Abstract: A method determines an analyte concentration in a sample. The sample includes the analyte and a substance. The method includes providing absorption data of the sample. The method further includes providing reference absorption data of the substance. The method further includes calculating a substance contribution of the absorption data. The method further includes subtracting the substance contribution from the absorption data, thereby providing corrected absorption data substantially free of a contribution from the substance.Type: GrantFiled: August 20, 2007Date of Patent: September 22, 2009Assignee: OptiScan Biomedical CorporationInventors: Bernhard B. Sterling, James R. Braig, Daniel S. Goldberger, Philip C. Hartstein, Robert D. Gaffney
-
Publication number: 20090213360Abstract: A reagentless whole-blood analyte detection system that is capable of being deployed near a patient has a source capable of emitting a beam of radiation that includes a spectral band. The whole-blood system also has a detector in an optical path of the beam. The whole-blood system also has a housing that is configured to house the source and the detector. The whole-blood system also has a sample element that is situated in the optical path of the beam. The sample element has a sample cell and a sample cell wall that does not eliminate transmittance of the beam of radiation in the spectral band.Type: ApplicationFiled: December 23, 2008Publication date: August 27, 2009Applicant: OPTISCAN BIOMEDICAL CORPORATIONInventors: James R. Braig, Peter Rule, Philip C. Hartstein, Bernhard B. Sterling, Jennifer H. Gable, Kenneth I. Li
-
Publication number: 20090192367Abstract: An embodiment of a system for analyzing a body fluid of a patient comprises a fluid transport network having a patient end configured to provide fluid communication with the body fluid in the patient and a fluid delivery point spaced from the patient end. A pump system is coupled to the fluid transport network. The pump system has an infusion mode in which the pump system is operable to pump an infusion fluid toward the patient end of the fluid transport network and a draw mode in which the pump system is operable to draw the body fluid from the patient into the fluid transport network through the patient end. At least one electrochemical test element is located near the fluid delivery point of the fluid transport network. The electrochemical test element is positioned to receive a portion of the body fluid delivered to the delivery point by the fluid transport network. An analyte detection system is configured to receive the test element and to measure at least one analyte in the portion of the body fluid.Type: ApplicationFiled: December 23, 2008Publication date: July 30, 2009Applicant: OptiScan Biomedical CorporationInventors: James R. Braig, Peter Rule
-
Publication number: 20090156911Abstract: Systems and methods for determining the concentration of an analyte in a sample such as bodily fluid are disclosed. Systems and methods disclosed herein comprise reducing the volume of sample withdrawn from the source of biological fluid. Low draw volume systems can be implemented using small inner diameter tube, valves and one or more sensors, for example. A method for calibrating a measurement of an analyte in a fluid sample for dilution of the fluid sample is also disclosed.Type: ApplicationFiled: October 8, 2008Publication date: June 18, 2009Applicant: OptiScan Biomedical CorporationInventors: Peter Rule, Richard Keenan
-
Publication number: 20090131861Abstract: Disclosed are methods and apparatus for determining analyte concentration in a sample such as bodily fluid. Systems and methods disclosed herein can also include a treatment dosing system to infuse or inject a treatment drug (e.g. insulin or glucose) and provide glycemic control. The dose of the treatment drug may be based on the concentration of the analyte or the average value for the concentration of the analyte and/or the rate of change of the value of the concentration of the analyte.Type: ApplicationFiled: October 10, 2008Publication date: May 21, 2009Applicant: OptiScan Biomedical CorporationInventors: James R. Braig, Richard Keenan, Peter Rule, Gil Rivas, Mahesh Seetharaman
-
Publication number: 20090036764Abstract: Various medical systems and methods are described, including a medical monitoring system. The medical monitoring system can have a fluid system configured to receive bodily fluid and optically analyze said fluid to determine analyte concentration. The fluid system can have a removable portion. The removable portion can have an opening with a port. The system can also have a container configured to contain anticoagulant. The container can have a portion configured to mate with the port of the removable portion. The container can be further configured to not fit into a conventional luer fitting. An anti-coagulant insertion apparatus is also described. The apparatus can have a syringe, a dock with a port, and an adapter configured to connect the syringe to the port. The dock can also have a tab configured to move with the port.Type: ApplicationFiled: May 19, 2008Publication date: February 5, 2009Applicant: OptiScan Biomedical CorporationInventors: Gil Rivas, Michael Butler, Jeffrey T. Chiou, Eugene Lim
-
Publication number: 20090032111Abstract: A fluid mixing device is described that is suitable for use in an analyte detection system. For example, intersecting fluid passageways having flow cross-sections are described. One or more of the fluid passageways can have one or more fluid mixing chambers, and the fluid mixing chamber(s) can have a wider cross-section than other portions of the fluid passageways. A mixing fluid can be introduced into a flow of main fluid at an intersection between fluid passageways, and fluid flow can be regulated by flow regulating devices or valves that are operatively associated with the fluid passageways. A controller can control fluid movement, for example, by controlling the valves. Fluid mixing can be facilitated by disruption of laminar flow. Turbulent flow can be introduced by the shape or width or position of fluid mixing chamber(s).Type: ApplicationFiled: May 19, 2008Publication date: February 5, 2009Applicant: OptiScan Biomedical CorporationInventors: Roger Tong, Jeffrey T. Chiou
-
Patent number: 7481787Abstract: A fluid handling module is configured for removable engagement with a reusable main fluid handling instrument. The module includes a module housing and a first fluid passageway extending from the module housing. The first fluid passageway has a patient end remote from the housing. The first fluid passageway is configured to provide fluid communication with a bodily fluid in a patient. A fluid component separator is in fluid communication with the first fluid passageway. The fluid component separator is configured to separate at least one component from a portion of the bodily fluid drawn from the patient. A spectroscopic sample cell is configured to hold at least a portion of the first component.Type: GrantFiled: December 21, 2005Date of Patent: January 27, 2009Assignee: OptiScan Biomedical CorporationInventors: Jennifer H. Gable, James R. Braig, Kenneth I. Li, Mark Wechsler, Peng Zheng, Richard Keenan
-
Patent number: 7480032Abstract: A reagentless whole-blood analyte detection system that is capable of being deployed near a patient has a source capable of emitting a beam of radiation that includes a spectral band. The whole-blood system also has a detector in an optical path of the beam. The whole-blood system also has a housing that is configured to house the source and the detector. The whole-blood system also has a sample element that is situated in the optical path of the beam. The sample element has a sample cell and a sample cell wall that does not eliminate transmittance of the beam of radiation in the spectral band.Type: GrantFiled: January 23, 2006Date of Patent: January 20, 2009Assignee: Optiscan Biomedical CorporationInventors: James R. Braig, Peter Rule, Philip C. Hartstein, Bernard B. Sterling, Jennifer H. Gable, Kenneth I. Li
-
Publication number: 20080268486Abstract: An analyte detection system is configured to measure concentrations of at least first and second analytes in a single material sample supported by a sample element. The measurement of a second analyte can be conditioned on a quantitative or qualitative result of the first measurement. In one embodiment, the first analyte is glucose and the second analyte is a ketone. According to such an embodiment the ketone is measured if the result of the glucose measurement exceeds a previously-specified value or falls outside of a previously-specified range.Type: ApplicationFiled: July 10, 2008Publication date: October 30, 2008Applicant: OptiScan Biomedical CorporationInventors: James R. Braig, Peter Rule, Kenneth G. Witte, Philip C. Hartstein, Bernhard B. Sterling
-
Publication number: 20080212071Abstract: A method determines an analyte concentration in a sample. The sample includes the analyte and a substance. The method includes providing absorption data of the sample. The method further includes providing reference absorption data of the substance. The method further includes calculating a substance contribution of the absorption data. The method further includes subtracting the substance contribution from the absorption data, thereby providing corrected absorption data substantially free of a contribution from the substance.Type: ApplicationFiled: August 20, 2007Publication date: September 4, 2008Applicant: OptiScan Biomedical CorporationInventors: Bernhard B. Sterling, James R. Braig, Daniel S. Goldberger, Philp C. Hartstein, Robert D. Gaffney
-
Publication number: 20080161723Abstract: Disclosed are systems, apparatus and methods for determining information related to analyte(s) (e.g., concentration) in a sample such as biological fluid. An analysis system for determining information relating to at least one analyte in a sample of biological fluid can be configured to: withdraw the sample of biological fluid from the source of biological fluid; interrupt the flow of infusion fluid while the sample of biological fluid is withdrawn; analyze the withdrawn biological fluid to determine information relating to at least one analyte; and resume the flow of infusion fluid after the sample of biological fluid is withdrawn. A method of interrupting flow of an infusion fluid without triggering an alarm can comprise, while the flow of the infusion fluid is interrupted, diverting the flow of the infusion fluid from a fluid passageway to an expandable volume at a rate that maintains constant flow from an infusion pump.Type: ApplicationFiled: September 6, 2007Publication date: July 3, 2008Applicant: OptiScan Biomedical CorporationInventors: Richard Keenan, Jeffrey Chiou, Peter Rule, James R. Braig